Diasome Pharmaceuticals broke through a challenging funding environment to raise $20M

Company executive Kent Manson talked to Cleveland Business Journal about the challenges of fundraising in a market roiled by inflation, rising interest rates and the fear of economic recession, not to mention the lingering effects of Covid.